环形戒指市场：现况分析与预测（2023-2030）

由于易患心臟瓣膜疾病的老年人口增加，瓣环成形环市场预计将以约3.53%的速度稳定成长。 例如，根据世界卫生组织(WHO)称，到2050年，全球60岁以上人口将翻一番，达到21亿。 此外，2020 年至 2050 年间，80 岁及以上的人口数量预计将增加两倍，达到 4.26 亿。 心臟病盛行率急剧上升、人们对心血管疾病的认识不断提高以及对心臟病学投资的增加等几个因素正在推动预测期内的市场成长。 除此之外，瓣环成形环提高了治疗效率，从而加快了治疗过程并提高了准确性，这也稳步推动了瓣环成形环市场的发展。

市场依刚性分为柔性、刚性、半刚性等。 到 2022 年，刚性部分将在细分市场中占据最大份额，因为它为二尖瓣提供稳定性。 刚性瓣环成形术环是用于心臟手术，特别是二尖瓣修復的装置。 这些环旨在支撑和重塑二尖瓣环，二尖瓣环是围绕瓣膜的纤维环。 由于冠心病和高血压患者数量不断增加，该细分市场占据了市场主导地位。 例如，心臟病家族史也是该细分市场的驱动因素。 因此，在刚性类型中，刚性环细分市场将在2022年占据很大的市场份额。

依应用，市场分为二尖瓣成形术、三尖瓣成形术、主动脉瓣成形术等。 由于三尖瓣逆流的盛行率不断上升，预计三尖瓣成形术领域在预测期内将占据相当大的市场份额。 例如，根据Science Direct 2023 年10 月报道，中度或重度三尖瓣逆流（TR）的发生率随着年龄的增长而增加，在一般人群中男性患病率达到1.5%，女性患病率达到5.6%。 三尖瓣瓣环成形术用于解决三尖瓣逆流 (TR) 等疾病，即心臟收缩时血液回流到右心房。 因此，应用中的三尖瓣成形术类别在预测期内将表现出较高的复合年增长率。

为了更了解环生环的市场介绍，我们根据其在北美、欧洲、亚太地区和世界其他地区的全球影响力对市场进行了分析。 截至 2022 年，由于老年人口不断增长以及开发有效环形形成环的投资不断增加，北美将主导市场。 例如，根据人口研究所的数据，65 岁及以上的美国人数量预计将从 2022 年的 5,800 万增加到 2050 年的 8,200 万（增加 47%）。 政府机构已启动心臟病意识计划，为患者提供有效的治疗。 除此之外，北美还拥有众多领先的医疗器材製造商，进一步推动了该地区环形塑胶环市场的成长。

该市场的主要参与者包括 Affluence Medical、Corcym、Braile Biomedica、Coronaneo、Edwards Lifesciences Corporation、Genesee BioMedical、HVR Cardio Oy、Medtronic、Abbott 和 Valcare Medical。

目录

第1章市场介绍

• 市场定义
• 主要目标
• 利害关係人
• 限制

第2章研究方法或前提

• 调查过程
• 调查方法
• 受访者简介

第3章市场总结

第 4 章执行摘要

第五章 COVID-19 对环形戒指市场的影响

第六章环形形成环市场收入（2020-2030）

第 7 章市场洞察：刚性

• 灵活
• 刚性
• 半刚性
• 其他

第 8 章市场洞察：按应用划分

• 二尖瓣环成形术
• 三尖瓣环成形术
• 主动脉瓣环成形术
• 其他

第 9 章市场洞察：按地区

• 北美
  • 美国
  • 加拿大
  • 北美其他地区
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 亚太地区其他地区
• 世界其他地区

第10章瓣环成形环市场动态

• 市场驱动因素
• 市场挑战
• 影响分析

第11章瓣环成形环市场机会

第12章瓣环成形环市场趋势

第13章需求方与供给方分析

• 需求方分析
• 供给面分析

第14章价值链分析

第15章竞争场景

• 竞争状况
  • 波特五力分析

第16章公司简介

• Affluent Medical
• Corcym
• Braile Biomedica
• Coroneo
• Edwards Lifesciences Corporation
• Genesee BioMedical
• HVR Cardio Oy
• Medtronic
• Abbott
• Valcare Medical

第17章 免责事项

Annuloplasty rings are devices used in cardiac surgery to treat mitral or tricuspid valve insufficiency. These rings are typically made of durable materials like titanium or polymers and are placed around the heart valve's annulus-the fibrous ring surrounding the valve leaflets. The primary purpose of annuloplasty rings is to restore the proper shape and size of the valve annulus, ensuring optimal valve function. They help in correcting valve regurgitation by providing structural support and preventing further dilation of the annulus. Annuloplasty rings have been gaining popularity in the market owing to several factors, such as increasing incidence of heart valve disorders, advancements in technology, growing minimally invasive procedures, increasing awareness and diagnosis, rising healthcare expenditure, rising regulatory support, and surge in company collaborations & partnerships are leading drivers of annuloplasty rings globally.

The Annuloplasty Rings Market is expected to grow at a steady rate of around 3.53% owing to the rising geriatric population which is more sensitive towards heart valve disorders. For instance, according to the World Health Organization, by 2050, the world's population of people aged 60 years and older will double to 2.1 billion. The population of number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million. Several factors, including a surge in the incidence of cardiac disorders, increasing awareness regarding cardiovascular disorders, and increased investments in cardiology departments are driving the growth of the market during the forecast period. Apart from this, accelerated treatment efficiency with annuloplasty rings has resulted in faster treatment procedures and better accuracy which is also driving this market of annuloplasty rings at a steady rate.

Based on rigidity, the market is segmented into flexible, rigid, semi-rigid, and others. The rigid segment held the maximum share in the global market of annuloplasty rings in 2022 owing to the stability it provides to the mitral valve. Rigid annuloplasty rings are devices used in cardiac surgery, particularly in mitral valve repair procedures. These rings are designed to support and reshape the mitral valve annulus, which is the fibrous ring surrounding the valve. This segment dominated the market because of the rising cases of coronary heart disease and high blood pressure. For instance, A family history of heart disease is also a propelling factor for this segment. Thus, among the rigidity type, the rigid ring segment held a significant share of the market in 2022.

Based on application, the market is categorized into mitral valve annuloplasty, tricuspid valve annuloplasty, aortic valve annuloplasty, and others. The tricuspid valve annuloplasty segment is expected to hold a significant share of the market in the forecast period owing to the rising prevalence of tricuspid regurgitation. For instance, in October 2023, according to Science Direct, the incidence of moderate or severe tricuspid regurgitation (TR) increases with age; the prevalence in the general population reaches 1.5% and 5.6% in men and women, respectively. Tricuspid valve annuloplasty is performed to address conditions such as tricuspid regurgitation (TR), where blood flows back into the right atrium during the heart's contraction. Thus, amongst applications, the tricuspid valve annuloplasty category is expected to witness a higher CAGR during the forecast period.

For a better understanding of the market adoption of annuloplasty rings, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is dominating the market in the current scenario of 2022 due to the increasing geriatric population, and rising number of investments in developing effective annuloplasty rings. For instance, according to the Population Reference Bureau, the number of Americans ages 65 and older is projected to increase from 58 million in 2022 to 82 million by 2050 (a 47% increase). Government organizations are initiating cardiac disorder awareness programs to provide efficient care to patients. Apart from these, North America has an enormous number of leading medical device manufacturers which is further propelling the growth of the annuloplasty ring market in the region.

Some of the major players operating in the market include Affluent Medical; Corcym; Braile Biomedica; Coroneo; Edwards Lifesciences Corporation; Genesee BioMedical; HVR Cardio Oy; Medtronic; Abbott; Valcare Medical.

TABLE OF CONTENTS

1. MARKET INTRODUCTION

• 1.1.Market Definitions
• 1.2.Main Objective
• 1.3.Stakeholders
• 1.4.Limitation

2. RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1.Research Process of the Annuloplasty Rings Market
• 2.2.Research Methodology of the Annuloplasty Rings Market
• 2.3.Respondent Profile

3. MARKET SYNOPSIS

4. EXECUTIVE SUMMARY

5. IMPACT OF COVID-19 ON THE ANNULOPLASTY RINGS MARKET

6. ANNULOPLASTY RINGS MARKET REVENUE (USD BN), 2020-2030F

7. MARKET INSIGHTS BY RIGIDITY

• 7.1.Flexible
• 7.2.Rigid
• 7.3.Semi-rigid
• 7.4.Others

8. MARKET INSIGHTS BY APPLICATION

• 8.1.Mitral valve annuloplasty
• 8.2.Tricuspid valve annuloplasty
• 8.3.Aortic valve annuloplasty
• 8.4.Others

9. MARKET INSIGHTS BY REGION

• 9.1.North America
  • 9.1.1.U.S.
  • 9.1.2.Canada
  • 9.1.3.Rest of North America
• 9.2.Europe
  • 9.2.1.Germany
  • 9.2.2.U.K.
  • 9.2.3.France
  • 9.2.4.Italy
  • 9.2.5.Spain
  • 9.2.6.Rest of Europe
• 9.3.Asia-Pacific
  • 9.3.1.China
  • 9.3.2.Japan
  • 9.3.3.India
  • 9.3.4.Rest of Asia-Pacific
• 9.4.Rest of World

10. ANNULOPLASTY RINGS MARKET DYNAMICS

• 10.1.Market Drivers
• 10.2.Market Challenges
• 10.3.Impact Analysis

11. ANNULOPLASTY RINGS MARKET OPPORTUNITIES

12. ANNULOPLASTY RINGS MARKET TRENDS

13. DEMAND AND SUPPLY-SIDE ANALYSIS

• 13.1.Demand Side Analysis
• 13.2.Supply Side Analysis

14. VALUE CHAIN ANALYSIS

15. COMPETITIVE SCENARIO

• 15.1.Competitive Landscape
  • 15.1.1.Porters Fiver Forces Analysis

16. COMPANY PROFILED

• 16.1.Affluent Medical
• 16.2.Corcym
• 16.3.Braile Biomedica
• 16.4.Coroneo
• 16.5.Edwards Lifesciences Corporation
• 16.6.Genesee BioMedical
• 16.7.HVR Cardio Oy
• 16.8.Medtronic
• 16.9.Abbott
• 16.10.Valcare Medical

17. DISCLAIMER